GALT
Galectin Therapeutics Inc
NASDAQ: GALT · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.89% today
Updated 2026-04-30
Market cap
$156.01M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.48
Dividend yield
—
52W range
$1 – $7
Volume
0.3M
Galectin Therapeutics Inc (GALT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $67000.00 | $64000.00 | $49000.00 | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $7000.00 | $7000.00 | $1000.00 | $1000.00 | $35000.00 | $36000.00 | $41000.00 | $32000.00 | $33000.00 | $37000.00 | — |
| Gross profit | $-7.05M | $-6.46M | $-5.33M | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $-7000.00 | $-7000.00 | $-1000.00 | $-1000.00 | $-35000.00 | $-36000.00 | $-41000.00 | $-32000.00 | $-33000.00 | $-37000.00 | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $3.02M | $2.05M | $1.77M | $1.11M | $1.07M | $3.55M | $4.53M | $5.69M | $8.43M | $13.11M | $15.32M | $11.72M | $6.47M | $7.47M | $17.98M | $23.82M | $31.74M | $32.13M | $36.57M | $14.29M |
| SG&A | $4.03M | $4.40M | $3.55M | $4.98M | $3.82M | $6.86M | $5.37M | $6.42M | $7.00M | $6.96M | $6.16M | $4.53M | $7.13M | $5.97M | $5.47M | $6.36M | $6.62M | $5.90M | $5.86M | $5.79M |
| Operating income | $-7.05M | $-6.46M | $-5.33M | $-6.09M | $-4.88M | $-10.41M | $-9.90M | $-12.10M | $-15.43M | $-20.08M | $-21.48M | $-16.25M | $-13.60M | $-13.44M | $-23.44M | $-30.18M | $-38.35M | $-38.07M | $-42.43M | $-20.09M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-1.28M | $-9.02M | $-3.10M | $-7.42M | $-5.62M | $-10.91M | $-9.67M | $-12.08M | $-15.42M | $-20.02M | $-21.47M | $-16.22M | $-13.56M | $-13.17M | $-23.34M | $-30.00M | $-37.71M | $-38.24M | $-41.47M | $-23.45M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-1.34M | $-9.08M | $-3.15M | $-7.46M | $-5.63M | $-10.91M | $-9.68M | $-12.09M | $-15.43M | $-20.03M | $-21.48M | $-16.22M | $-13.56M | $-13.21M | $-23.38M | $-30.04M | $-37.74M | $-38.27M | $-41.51M | $-23.51M |
| Interest expense | $1.85M | $350000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12000.00 | $336000.00 | $87000.00 | $87000.00 | $489000.00 | $1.03M | $2.79M | $5.54M | $7.33M |
| Income tax | $-3.85M | $2.98M | $-2.17M | $1.37M | $746000.00 | $506000.00 | $200000.00 | $16000.00 | $-52000.00 | $0.00 | $0.00 | $24000.00 | $0.00 | $87000.00 | $51000.00 | $448000.00 | $424000.00 | $-2.99M | — | — |
| Effective tax rate | 54.7% | -46.1% | 40.8% | -22.5% | -15.3% | -4.9% | -2.1% | -0.1% | 0.3% | 0.0% | 0.0% | -0.1% | 0.0% | -0.7% | -0.2% | -1.5% | -1.1% | 6.8% | 0.0% | 0.0% |
| Net income | $-3.19M | $-9.43M | $-3.15M | $-7.46M | $-5.63M | $-10.91M | $-9.68M | $-12.09M | $-15.79M | $-20.03M | $-21.44M | $-16.23M | $-13.90M | $-13.29M | $-23.46M | $-30.53M | $-38.78M | $-41.07M | $-47.05M | $-30.84M |
| Net income growth (YoY) | — | -195.4% | +66.6% | -136.8% | +24.6% | -93.9% | +11.4% | -24.9% | -30.6% | -26.8% | -7.0% | +24.3% | +14.4% | +4.4% | -76.5% | -30.1% | -27.0% | -5.9% | -14.6% | +34.5% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |